VIDEO: Black patients less likely to receive MRI before prostate cancer diagnosis
CHICAGO — In this Healio video exclusive, Stephen J. Freedland, MD, discusses the underutilization of MRI-guided biopsies before prostate cancer diagnosis in different racial groups.
Freedland, urologist at Cedars-Sinai Medical Center and Durham VA Medical Center, spoke about the research by Grace Lu-Yao, PhD, MPH, and colleagues presented at the ASCO Annual Meeting. MRI allows clinicians to better identify and detect prostate cancer; however, current guidelines on MRI-guided biopsy are inconsistent, according to researchers.
Among 38,612 eligible men, MRI use 6 months before diagnosis increased from 2012 to 2017 — 3.2% to 24.3% among white patients and 1.8% to 14.2% among Black patients. Compared with white patients, Black patients were 38% less likely to receive pre-diagnosis MRI, according to researchers.
“We know in an older era where we didn’t have MRIs and all of the therapies we have, Black men were more likely to get prostate cancer and more likely to die,” Freedland said. “As we roll out new therapies and improve outcomes, the Black men are being left behind. We’re going to create even more disparities in prostate cancer outcomes compared to historical data, which is quite shocking.”
Reference :
- Lu-Yao G, et al. Abstract 5093. Presented at: ASCO Annual Meeting; June 2-6, 2023; Chicago.
Collapse
Healio interviews
Read more about